Phase 2a Study of PRV-6527 in Subjects With Moderately to Severely Active Crohn's Disease

Efficacy, Safety and Tolerability of AIN457 in Moderate to Severe Active Crohn's Disease

NCT00584740 ·Status: TERMINATED ·Phase: PHASE2

A Study Evaluating Participants With Moderately to Severely Active Crohn's Disease

NCT04102111 ·Status: TERMINATED ·Phase: PHASE2

Observational Study of Disease Severity in Participants Diagnosed With Crohn's Disease and Long Term Impact of Treatment Strategies in Participants With Moderate to Severe Crohn's Disease (Protocol P06484)

NCT01218360 ·Status: COMPLETED

Safety and Efficacy of NNC 0142-0000-0002 in Subjects With Moderately to Severely Active Crohn's Disease

NCT01203631 ·Status: COMPLETED ·Phase: PHASE2

Study to Evaluate Safety, Tolerability and Efficacy of GSK2330811 in Crohn's Disease

NCT04151225 ·Status: WITHDRAWN ·Phase: PHASE2

A Study To Investigate Safety And Efficacy Of CP-690,550 For Induction Therapy In Subjects With Moderate To Severe Crohn's Disease

NCT01393626 ·Status: COMPLETED ·Phase: PHASE2

A Study to Evaluate the Efficacy and Safety of CCX282-B in Subjects With Moderate to Severe Crohn's Disease

NCT00306215 ·Status: COMPLETED ·Phase: PHASE2

A Six Week Efficacy, Safety and Tolerability Study of V565 in Crohn's Disease

NCT02976129 ·Status: COMPLETED ·Phase: PHASE2

Evaluation of Efficacy and Safety of MEDI2070 in Patients With Active, Moderate-to-severe Crohn's Disease.

NCT01714726 ·Status: COMPLETED ·Phase: PHASE2

Efficacy Study of Targeted, Local Delivery of Drugs to Treat Crohn's Disease

NCT00287170 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Safety and Efficacy of MT-1303 in Subjects With Moderate to Severe Active Crohn's Disease

NCT02378688 ·Status: COMPLETED ·Phase: PHASE2

A Phase II Study to Assess the Efficacy and Safety of Olokizumab in Patients With Crohn's Disease

NCT01635621 ·Status: WITHDRAWN ·Phase: PHASE2

Efficacy & Safety in Moderately Active Refractory Ulcerative Colitis Patients

NCT01375179 ·Status: TERMINATED ·Phase: PHASE2

CP-461 for the Treatment of Crohn's Disease

NCT00042055 ·Status: COMPLETED ·Phase: PHASE2

Nine-Weeks Treatment With 683699 In Subjects With Moderately-To-Severely Active Crohn's Disease

NCT00101946 ·Status: COMPLETED ·Phase: PHASE2

Study Evaluating ERB-041 in Active Crohn's Disease

NCT00245947 ·Status: COMPLETED ·Phase: PHASE1

A Study to Investigate the Efficacy and Safety of GSK1605786A in the Treatment of Subjects With Moderately-to-Severely Active Crohn's Disease

NCT01277666 ·Status: COMPLETED ·Phase: PHASE3

Extended Evaluation of PROCHYMAL® Adult Human Stem Cells for Treatment-Resistant Moderate-to-Severe Crohn's Disease

NCT00543374 ·Status: COMPLETED ·Phase: PHASE3

A Study of Icotrokinra in Participants With Moderately to Severely Active Crohn's Disease

NCT07196722 ·Status: RECRUITING ·Phase: PHASE2/PHASE3

A Randomized, Double-blind, Study to Explore the Effect of GED-0301 in Subjects With Active Crohn's Disease

NCT02367183 ·Status: COMPLETED ·Phase: PHASE1

Phase 3 Study of Human TH-SC01 Cell Injection for Treating Perianal Fistulas in Patients With Crohn's Disease

NCT06925594 ·Status: RECRUITING ·Phase: PHASE3

A Study to Evaluate the Efficacy, Safety, and Drug Levels of Oral Ozanimod in Pediatric Participants With Moderately to Severely Active Crohn's Disease With an Inadequate Response to Conventional Therapy

NCT05470985 ·Status: TERMINATED ·Phase: PHASE2/PHASE3

VTX958 for the Treatment of Moderately to Severely Active Crohn's Disease

NCT05688852 ·Status: TERMINATED ·Phase: PHASE2

Efficacy and Safety of GLPG0634 in Subjects With Active Crohn's Disease

NCT02048618 ·Status: COMPLETED ·Phase: PHASE2

Safety and Efficacy of Natalizumab in the Treatment of Crohn's Disease

NCT00032799 ·Status: COMPLETED ·Phase: PHASE3